000 01181 a2200361 4500
005 20250513230107.0
264 0 _c20010628
008 200106s 0 0 eng d
022 _a0028-3878
024 7 _a10.1212/wnl.56.1.97
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCiafaloni, E
245 0 0 _aMycophenolate mofetil for myasthenia gravis: an open-label pilot study.
_h[electronic resource]
260 _bNeurology
_cJan 2001
300 _a97-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMyasthenia Gravis
_xdrug therapy
650 0 4 _aMycophenolic Acid
_xadministration & dosage
650 0 4 _aPilot Projects
650 0 4 _aTreatment Outcome
700 1 _aMassey, J M
700 1 _aTucker-Lipscomb, B
700 1 _aSanders, D B
773 0 _tNeurology
_gvol. 56
_gno. 1
_gp. 97-9
856 4 0 _uhttps://doi.org/10.1212/wnl.56.1.97
_zAvailable from publisher's website
999 _c11088130
_d11088130